Leading Biology….. A New Weapon for Cancer
MiReven is commercialising the pioneering work of Prof Peter Leedman and Dr Keith Giles at the Harry Perkins Institute of Medical Research on the anti-cancer potential of miR-7.
- miReven Scientists Awarded $530k Grant to Advance miR-7 Cancer Therapeutic 19 November 2015
- microRNA-7: A tumor suppressor miRNA with therapeutic potential 24 July 2014
- MiReven Receives United States Patent 30 April 2014
- MiReven Wins 2013 Western Australia Innovator of the Year Award 14 November 2013